论文部分内容阅读
目的:观察健脾益肾中药联合化疗治疗晚期非小细胞肺癌(NSCLC)患者的疗效及其对生活质量的影响。方法:将60例晚期非小细胞肺癌患者随机分为中药联合化疗组(中药加化疗)30例,单纯化疗组(单纯化疗)30例,治疗2个疗程后,观察其病灶大小变化及不良反应,并观察治疗前后卡氏评分、体重等指标变化。结果:中药联合化疗组卡氏评分及生活质量均有不同程度提高,与单纯化疗组比较差异有显著性(P<0.05),但在不良反应方面,两组比较差异无显著性。结论:这表明健脾益肾补血法联合化疗能有效提高晚期NSCLC的临床疗效,改善生活质量。
Objective: To observe the curative effect of Jianpi Yishen combined with chemotherapy on patients with advanced non-small cell lung cancer (NSCLC) and its effect on quality of life. Methods: Sixty patients with advanced non-small cell lung cancer were randomly divided into three groups: 30 cases of combined traditional Chinese medicine (TCM plus chemotherapy) and 30 cases of simple chemotherapy (chemotherapy alone). After 2 courses of treatment, the changes of their size and adverse reactions , And observed before and after treatment, the Karlsruhe score, weight and other indicators change. Results: The Karnofsky scores and quality of life in the combination chemotherapy group were all improved to some extent, compared with the chemotherapy alone group (P <0.05). However, there was no significant difference in adverse reactions between the two groups. Conclusion: This shows that the spleen and kidney therapy combined with chemotherapy can effectively improve the clinical efficacy of advanced NSCLC, improve the quality of life.